METHOD FOR DEFINING A RANGE FOR CLOSED SUBSCRIBER GROUP IDENTITIES FOR AN OPEN NETWORK ACCESS POINT.

摘要

Method for the operation of one or more radio cells in a cellular mobile radio network and cellular mobile radio system, wherein each radio cell can be identified by a transmitted cell identifier, wherein the use can be limited to a closed subscriber group by virtue of the radio cell having an appropriate identifier and by virtue of mobile radio terminals registering in the respective radio cell for use of the services of the mobile radio network only following a positive comparison with a positive list of authorized cell identifiers which is stored in the mobile radio terminal, wherein the cell identifier is variable and it is possible to use the cell identifier to establish whether registration and use of the network services is currently limited to the closed subscriber group or whether alternatively registration and use of the network services is cleared for any subscribers. Method for the operation of one or more radio cells in a cellular mobile radio network and cellular mobile radio system, wherein each radio cell can be identified by a transmitted cell identifier, wherein the use can be limited to a closed subscriber group by virtue of the radio cell having an appropriate identifier and by virtue of mobile radio terminals registering in the respective radio cell for use of the services of the mobile radio network only following a positive comparison with a positive list of authorized cell identifiers which is stored in the mobile radio terminal, wherein the cell identifier is variable and it is possible to use the cell identifier to establish whether registration and use of the network services is currently limited to the closed subscriber group or whether alternatively registration and use of the network services is cleared for any subscribers. The present invention relates to methods for the identification of ligand recognition domains (LRD) in ligand-binding proteins or the identification of ligand-containing molecules, to diagnostic assays and kits for carrying out said methods and to peptides comprising LRD sequences.